Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Eric Tarride

Showing results (21-30 of 215) with videos related to

Pageof 22
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|September 26, 2019
A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patientsJean-Eric Tarride, Trinh Luong, Gordon Goodall, et al.
Pharmacoeconomics - Open|May 2, 2019
A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private PayersNaghmeh Foroutan, Jean-Eric Tarride, Feng Xie, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 15, 2014
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Genetic Testing and Molecular Biomarkers|September 27, 2012
Economic evaluations conducted for assessment of genetic testing technologies: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Hospital Practice (1995)|May 23, 2012
Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi studyFeng Xie, Rob Hopkins, Natasha Burke, et al.
Autism : the International Journal of Research and Practice|April 5, 2019
Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort studyCaroline Croteau, Laurent Mottron, Marc Dorais, et al.
International Journal of Technology Assessment in Health Care|July 17, 2015
Barriers and facilitators influencing ethical evaluation in health technology assessmentNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Clinical Therapeutics|June 20, 2007
A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targetsJean Lachaine, Elizabeth Merikle, Jean-Eric Tarride, et al.
Journal of Aging Research|January 10, 2012
How does the canadian general public rate moderate Alzheimer's disease?Jean-Eric Tarride, Mark Oremus, Eleanor Pullenayegum, et al.
International Journal of Circumpolar Health|September 20, 2011
Health economic evaluations help inform payers of the best use of scarce health care resourcesDaria O'Reilly, Kathryn Gaebel, Feng Xie, et al.
Pageof 22

Showing results (21-30 of 215) with videos related to

Sort By:
Pageof 22
Clinicoeconomics and Outcomes Research : CEOR|September 26, 2019
A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patientsJean-Eric Tarride, Trinh Luong, Gordon Goodall, et al.
Pharmacoeconomics - Open|May 2, 2019
A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private PayersNaghmeh Foroutan, Jean-Eric Tarride, Feng Xie, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 15, 2014
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Genetic Testing and Molecular Biomarkers|September 27, 2012
Economic evaluations conducted for assessment of genetic testing technologies: a systematic reviewNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Hospital Practice (1995)|May 23, 2012
Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi studyFeng Xie, Rob Hopkins, Natasha Burke, et al.
Autism : the International Journal of Research and Practice|April 5, 2019
Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort studyCaroline Croteau, Laurent Mottron, Marc Dorais, et al.
International Journal of Technology Assessment in Health Care|July 17, 2015
Barriers and facilitators influencing ethical evaluation in health technology assessmentNazila Assasi, Lisa Schwartz, Jean-Eric Tarride, et al.
Clinical Therapeutics|June 20, 2007
A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targetsJean Lachaine, Elizabeth Merikle, Jean-Eric Tarride, et al.
Journal of Aging Research|January 10, 2012
How does the canadian general public rate moderate Alzheimer's disease?Jean-Eric Tarride, Mark Oremus, Eleanor Pullenayegum, et al.
International Journal of Circumpolar Health|September 20, 2011
Health economic evaluations help inform payers of the best use of scarce health care resourcesDaria O'Reilly, Kathryn Gaebel, Feng Xie, et al.
Pageof 22